Individuals Discontinuing Slimming Injections Regain Weight Far More Rapidly Compared to Dieters

New research indicates that individuals who discontinue new slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass far faster than those who stop traditional lifestyle regimens.

Research printed in a major health publication demonstrates that while overweight individuals frequently drop a large proportion of their total mass while using the jabs, the mass returns at an average rate of nearly a kilo each month upon discontinuation.

"Users using such treatments must be aware of the danger of quick rebound weight gain when the treatment ends," cautioned lead investigator Dr. Susan Jebb.

This pace of regain implies a reversion to pre-treatment weight in about 18 months.

Weighing Therapies

The analysis, which examined dozens of studies involving thousands of patients, compared the effects of GLP-1 agonists with conventional dieting.

Researchers note that people who lose weight through diet and exercise usually experience a more gradual weight regain—around 100 grams monthly—post-intervention.

The Reason for the Quick Regain

Nutrition scientists believe the mechanism of the injections accounts for the amplified weight return.

These medications imitate a body's own chemical called GLP-1, which helps regulate feelings of fullness.

"Long-term administration of the hormone concentrations far above than the body's typical production might result in the system to generate a reduced amount of its endogenous GLP-1, and may also diminish sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this medication means appetite is unsuppressed, making binge eating much more probable."

A Chronic Issue?

The NHS advise the jabs for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.

Professionals argue that, due to the significant potential of weight regain, the therapy might need to be long-term.

This perspective is supported by drug manufacturers, who note that the findings "underscore the long-term nature of excess weight," akin to managing conditions like hypertension.

User Testimonies

Users who have come off the medication describe a intense return of appetite.

"It felt as if something activating and you're instantly starving," described one woman.

This challenge is worsened if users have not adopted permanent lifestyle or habit changes during treatment.

Significant Use

Survey data indicate that millions of people in the UK have tried these injections in the past year, with demand being substantial.

• Use is more common among women than men.
• The 40s and 50s demographic shows the greatest usage rates.
• Many obtain the medications through private healthcare rather than public health services.

Finally, experts caution that while GLP-1 drugs are powerful tools for weight loss, they are not a permanent fix and long-term success hinges on ongoing lifestyle management.